Berengere Hennebelle

Berengere Hennebelle is an experienced professional in regulatory strategy, currently serving as a Senior Manager for CMC Regulatory Strategy in Biotech Products at Ipsen since September 2024, with a focus on IND phase 1 oncology for bispecific antibodies and ADCs. Prior to this role, Berengere Hennebelle worked at Acticor Biotech as a Regulatory Manager, overseeing CMC regulatory strategy and IMPD/IND coordination from June 2022 to September 2024. As Head of CMC Regulatory/Compliance at GenSight Biologics between June 2020 and May 2022, Berengere Hennebelle managed regulatory strategies and procedures for gene therapy products. Additional experience includes serving as Regulatory Affairs Project Manager at LFB, where responsibilities included leading CMC regulatory work packages for biologics, and as Chef de Projet Développement Pharmaceutique/CMC Réglementaire at HRA Pharma, focusing on pharmaceutical development projects and regulatory strategies from July 2010 to January 2019.